Introduction
Ensure reliable and regulatory-aligned genotoxicity testing of drugs with our advanced in silico genotoxicity assessment services. PI Health Sciences uses computational toxicology, (Q)SAR models, and expert interpretation to complement traditional genotoxicity assays and meet global regulatory frameworks such as ICH M7.
Our approach helps pharmaceutical and biotech teams predict mutagenic risk early, streamline impurity evaluations, and support submission-ready documentation.
We provide:
- Hazard Screening for early-stage libraries.
- Impurity Assessment for regulatory submissions.
- (Q)SAR Predictions using two complementary models.
- Expert-Reviewed Reports with clear justifications.
See our full process, from computational screening to expert interpretation and regulatory support.
Download the full brochure to learn more!
